|Bid||56.38 x 1100|
|Ask||56.28 x 900|
|Day's range||55.26 - 56.47|
|52-week range||40.67 - 69.95|
|Beta (5Y monthly)||1.17|
|PE ratio (TTM)||27.76|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Integra (IART) notices recovery in procedure volumes leading to solid growth across most of its product portfolio in Q3.
Integra (IART) delivered earnings and revenue surprises of 19.44% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?